Merck Sharp & Dohme, Wilson Facility recalls Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, R…
- Recall date
- August 14, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0007-2016
- FDA classification
- Class II
- Brand / firm
- Merck Sharp & Dohme, Wilson Facility
- Sold / distributed
- KY, MS and OH.
Why it was recalled
Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx Only, 1000 count Bottle, Manuf. For Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, NDC 66582-0312-82.
Get recall alerts
Free email alert whenever Merck Sharp & Dohme, Wilson Facility has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Merck Sharp & Dohme, Wilson Facility